A total of 17 volunteers were administered Russia’s Sputnik V Covid-19 vaccine at a Pune hospital on Sunday as part of the human clinical trials.
Seventeen healthy volunteers were administered Russia’s Sputnik V Covid-19 vaccine in Pune. (AP)
Seventeen volunteers were administered Russia’s Sputnik V coronavirus vaccine at a Pune hospital in Maharashtra as part of phase-II human clinical trials, doctors said on Sunday.
Sputnik V vaccine has been developed by the Gamaleya National Research Center of Epidemiology and Microbiology and Russian Direct Investment Fund (RDIF). According to media reports, India has purchased 100 million doses of the candidate from Russia.
“Twenty-seven volunteers had registered their names by online registration. Each one of the 27 underwent RT PCR test. only 17 were cleared as they did not have any other complicated aliment. These 17 had no symptoms and never tested positive for coronavirus. These healthy volunteers were administered Sputnik V vaccine in the last three days as part of the human trials,” said Dr S K Raut, Head of Clinical Research Department of Noble Hospital, where the phase-II trials are on.
“All the volunteers, who were administered the vaccine, will be under observation for the next few days,” Dr Raut added.
The third phase trials of the vaccine are planned to be held at the KEM Hospital Research Centre located near Pune, another doctor said.
Besides Pune, trials for this vaccine are also planned to be held in Lucknow and Kanpur (Uttar Pradesh), Jaipur (Rajasthan), Vellore (Tamil Nadu), Mysore (Karnataka) and Puducherry, reported news agency PTI.
(With PTI inputs)